ArticleBritish journal of cancer2014

KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition.

H Hamidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.